Editor Pick

Biodefense Headlines – April 30, 2026

News Scan April 30, 2026

This week’s selections include cascading institutional disruptions reshaping U.S. public health and science governance — including the Trump administration’s mass firing of the National Science Board and restrictions on graduate…

Pediatric Neurologic Complications Emerge in a Severe U.S. Flu Season

Keeping Pace with a Moving Target: WHO Sets 2026 Southern Hemisphere Influenza Vaccine Composition

Emergency Departments Could Bridge Gaps in Adult Vaccination Coverage

Building Trust in Science: A New Framework for Public Engagement in Clinical Research

Last Flu Season Saw Highest U.S. Hospitalization Rates in Over a Decade

Q Fever May Be Complicating the Diagnostic Picture of Persistent Fevers

U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure Contracts

New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum Antivirals

Advances in Botulinum Neurotoxin Detection

Building Europe’s Health Shield: New EU4Health Calls Advance Medical Countermeasures and Diagnostics

Even a Small Decline in MMR Vaccine Rates Raises Big Measles Risk for States

America First, Health Last?

A Shrinking Safety Net: How the House FY26 Appropriations Bill Threatens Public Health Security

New Antibiotic Options Show Promise Against Biothreat Pathogens

Emerging Biotechnologies and Biosecurity Risks: A New Framework for Assessing Malicious Use

Study Warns of Rising Threat from HPAI H5N1 in Swine

New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis Bacterium

Building America’s Biosurveillance Radar: AI and Metagenomics for Early Pathogen Detection

Drug Shortages, Public Health Preparedness, and the Contradictions of U.S. Policy

Two Years On: MVA-BN Vaccine Still Shields Against Severe Mpox, But Equity and Boosters Loom as Next Frontiers

Biodefense Headlines – April 30, 2026